Turn Therapeutics Inc（TTRX）價格預測TTRXTurn Therapeutics Inc

Alphio's TTRX stock price prediction model matches the current Turn Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.54 (-0.68%). The 1-week path is $10.66 (+0.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Turn Therapeutics Inc. (TTRX) is a good buy right now, as it is currently priced at $10.28, significantly lower than the analyst price target of $24, indicating a potential upside of 134%. Additionally, the recent Phase 2 trial results for GX-03 show that 92.6% of participants achieved a 50% reduction in eczema severity, which could drive future revenue growth. The main risk is the company's high debt to equity ratio of 882.68%, which indicates significant financial leverage and potential vulnerability.

Turn Therapeutics Inc (TTRX) last closed at $10.6099997, gaining +3.21%. These facts feed the 1-day and 1-week TTRX price prediction above.